- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Corcept Therapeutics Inc+ Add to Watchlist
CORT:US2.5400 USD 0.2900 12.89%
As of 20:10:00 ET on 12/12/2013.
Company Profile for Corcept Therapeutics Inc (CORT)
Corcept Therapeutics Inc. is a pharmaceutical company that discovers and develops drugs for the treatment of severe metabolic and psychiatric disorders. The Company's lead product modulates the effect of cortisol, also known as the "stress hormone", by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor.
Corcept Therapeutics Inc
Key Executives for Corcept Therapeutics Inc (CORT)
|Joseph K BelanoffCEO/Co-Founder||Robert L RoePresident/Secretary|
|Gary Charles Robb "Charlie"Chief Financial Officer||Steven LoSenior VP/Chief Commercial Ofcr|
|Anne M LedouxVP/Chief Acctg Officer|